SCHEMBL19399634

SCHEMBL19399634

O=C(O)Cc1nc2cc(Cl)cc(Cl)c2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKAG1 P54619 4/20 0.42
▸ PRKAA2 P54646 4/20 0.42
▸ PRKAB1 Q9Y478 4/20 0.42
▸ PRKAA1 Q13131 1/20 0.42
▸ HRH4 Q9H3N8 1/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ PRKCZ Q05513 2/20 0.36
▸ MAOA P21397 1/20 0.36
▸ MAOB P27338 1/20 0.36
▸ HPSE Q9Y251 1/20 0.34
▸ AKR1B1 P15121 1/20 0.34
▸ GRIN1 Q05586 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ GRIN2D O15399 1/20 0.34
▸ GRIN3B O60391 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ GRIN2A Q12879 1/20 0.34
▸ GRIN2B Q13224 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17513286 0.82 MAPT (0.50) HRH4MAOAMAOBKDM4EALDH1A1
SCHEMBL31715979 0.79 PRKAG1 (0.43) PRKAG1PRKAA2PRKAB1PRKAA1NPC1
SCHEMBL10284441 0.77 GAA (0.54) HRH4GRIN1KDM4EGRIN2DGRIN3B
SCHEMBL3100859 0.75 RAB9A (0.52) PRKAG1PRKAA2PRKAB1PRKAA1NPC1
SCHEMBL31716315 0.74 PRKAG1 (0.72) PRKAG1PRKAA2PRKAB1PRKAA1PRKCZ
SCHEMBL15844358 0.74 RAD52 (0.43) PRKAG1PRKAA2PRKAB1PRKAA1GRIN1
Hydrochloric Acid SCHEMBL5111382 0.74 RAB9A (0.51) PRKAG1PRKAA2PRKAB1PRKAA1NPC1
SCHEMBL24553685 0.73 CSNK2A1 (0.34) GRIN1KDM4EGRIN2DGRIN3BALDH1A1
SCHEMBL29732979 0.73 CSNK2A1 (0.34) GRIN1KDM4EGRIN2DGRIN3BALDH1A1
SCHEMBL19377819 0.73 ALDH1A1 (0.55) NPC1RAB9AKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10913736-B2 Specific inhibitors of methionyl-tRNA synthetase UNIVERSITY OF WASHINGTON (US) 2021-02-09 — — US disclosed
US-20170275279-A1 SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE UNIVERSITY OF WASHINGTON 2017-09-28 — — US disclosed
US-20170275279-A1 SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE UNIVERSITY OF WASHINGTON 2017-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275279-A1 SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE AARS1, MTR, GARS1 PRKAG1 1504/4885PRKAA2 803/4885PRKAB1 1806/4885
US-10913736-B2 Specific inhibitors of methionyl-tRNA synthetase AARS1, MTR, GARS1 PRKAG1 1504/4885PRKAA2 803/4885PRKAB1 1806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback